| SOCS proteins, cytokine signalling and immune regulation A Yoshimura, T Naka, M Kubo Nature Reviews Immunology 7 (6), 454-465, 2007 | 1908 | 2007 |
| Structure and function of a new STAT-induced STAT inhibitor T Naka, M Narazaki, M Hirata, T Matsumoto, S Minamoto, A Aono, ... Nature 387 (6636), 924-929, 1997 | 1743 | 1997 |
| The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation T Kawabe, T Naka, K Yoshida, T Tanaka, H Fujiwara, S Suematsu, ... Immunity 1 (3), 167-178, 1994 | 1426 | 1994 |
| The paradigm of IL-6: from basic science to medicine T Naka, N Nishimoto, T Kishimoto Arthritis Research & Therapy 4, 1-10, 2002 | 842 | 2002 |
| SOCS-1 participates in negative regulation of LPS responses R Nakagawa, T Naka, H Tsutsui, M Fujimoto, A Kimura, T Abe, E Seki, ... Immunity 17 (5), 677-687, 2002 | 799 | 2002 |
| Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells A Kimura, T Naka, K Nohara, Y Fujii-Kuriyama, T Kishimoto Proceedings of the National Academy of Sciences 105 (28), 9721-9726, 2008 | 615 | 2008 |
| IL-6-dependent and-independent pathways in the development of interleukin 17-producing T helper cells A Kimura, T Naka, T Kishimoto Proceedings of the National Academy of Sciences 104 (29), 12099-12104, 2007 | 490 | 2007 |
| Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses A Kimura, T Naka, T Nakahama, I Chinen, K Masuda, K Nohara, ... Journal of Experimental Medicine 206 (9), 2027-2035, 2009 | 473 | 2009 |
| IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis S Serada, M Fujimoto, M Mihara, N Koike, Y Ohsugi, S Nomura, ... Proceedings of the National Academy of Sciences 105 (26), 9041-9046, 2008 | 427 | 2008 |
| Therapeutic strategies in epithelial ovarian cancer A Kim, Y Ueda, T Naka, T Enomoto Journal of experimental & clinical cancer research 31, 1-8, 2012 | 400 | 2012 |
| Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice T Naka, T Matsumoto, M Narazaki, M Fujimoto, Y Morita, Y Ohsawa, ... Proceedings of the National Academy of Sciences 95 (26), 15577-15582, 1998 | 361 | 1998 |
| Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling M Narazaki, M Fujimoto, T Matsumoto, Y Morita, H Saito, T Kajita, ... Proceedings of the National Academy of Sciences 95 (22), 13130-13134, 1998 | 337 | 1998 |
| Regulation of cytokine signaling by SOCS family molecules M Fujimoto, T Naka Trends in immunology 24 (12), 659-666, 2003 | 296 | 2003 |
| Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation Y Seki, K Hayashi, A Matsumoto, N Seki, J Tsukada, J Ransom, T Naka, ... Proceedings of the National Academy of Sciences 99 (20), 13003-13008, 2002 | 289 | 2002 |
| Interleukin‐6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses M Fujimoto, S Serada, M Mihara, Y Uchiyama, H Yoshida, N Koike, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 277 | 2008 |
| Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3 S Minamoto, K Ikegame, K Ueno, M Narazaki, T Naka, H Yamamoto, ... Biochemical and biophysical research communications 237 (1), 79-83, 1997 | 229 | 1997 |
| SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo T Naka, H Tsutsui, M Fujimoto, Y Kawazoe, H Kohzaki, Y Morita, ... Immunity 14 (5), 535-545, 2001 | 218 | 2001 |
| Contribution of Toll‐like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration E Seki, H Tsutsui, Y Iimuro, T Naka, G Son, S Akira, T Kishimoto, ... Hepatology 41 (3), 443-450, 2005 | 217 | 2005 |
| iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases S Serada, M Fujimoto, A Ogata, F Terabe, T Hirano, H Iijima, S Shinzaki, ... Annals of the rheumatic diseases 69 (4), 770-774, 2010 | 215 | 2010 |
| Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis S Serada, M Fujimoto, F Terabe, H Iijima, S Shinzaki, S Matsuzaki, ... Inflammatory bowel diseases 18 (11), 2169-2179, 2012 | 211 | 2012 |
